| Literature DB >> 34752055 |
Haoting Li1, Anne E Mattingly1, Leigh A Jania2, Richard Smith3, Roberta J Melander1, Robert K Ernst3, Beverley H Koller2, Christian Melander1.
Abstract
Multidrug-resistant bacterial infections have become a global threat. We recently disclosed that the known IKK-β inhibitor IMD-0354 and subsequent analogues abrogate colistin resistance in several Gram-negative strains. Herein, we report the activity of a second-generation library of IMD-0354 analogues incorporating a benzimidazole moiety as an amide isostere. We identified several analogues that show increased colistin potentiation activity against Gram-negative bacteria.Entities:
Keywords: Acinetobacter baumannii; Klebsiella pneumoniae; antibiotic adjuvant; colistin resistance
Mesh:
Substances:
Year: 2021 PMID: 34752055 PMCID: PMC8958665 DOI: 10.1021/acsinfecdis.1c00463
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084